Stay updated on Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Updated study timeline: primary completion listed as 2026-06 and study completion as 2026-09. Last update posted on 2026-04-02.
    Difference
    0.3%
    Check dated 2026-04-03T05:14:51.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed as part of a version update. This appears to be a backend or UI update with no changes to the study information displayed on the page.
    Difference
    0.1%
    Check dated 2026-03-19T19:09:15.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T15:00:44.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Added primary peritoneal carcinoma and fallopian tube cancer to the listed conditions, and introduced the Genetic and Rare Diseases Information Center as a new resource. Updated page revision to v3.4.2 and removed the prior funding-status notice (v3.4.1).
    Difference
    0.6%
    Check dated 2026-02-11T21:07:02.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page adds a site-wide government funding/status notice and updates the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T11:15:15.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Added 'Show glossary' and updated footer labels, including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision note 'Revision: v3.4.0' (replacing v3.3.4). These changes do not modify core study data or essential information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T07:27:10.000Z thumbnail image

Stay in the know with updates to Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.